Navigation Links
Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time
Date:5/12/2008

CHENGDU, China, May 12 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (OTC Bulletin Board: TYNP), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that the Company will present at Roth Third Annual China Discovery Tour on Tuesday, May 20, 2008 at 12:40 p.m. Beijing time. The Conference will be held at the Regent Hotel in Beijing, China.

Dr. Guoqing, Jiang, Tianyin's Chairman and CEO, Mr. Allen Tang, assistant to the CEO, will be representing Tianyin Pharmaceutical at the conference and will be available for one-on-one meetings with analysts and investors throughout the day.

Management will discuss the Company's current product portfolio, development pipeline, research and development platform, recent financial highlights and its long-term growth strategy.

Participation is by invitation and registration is mandatory. For more information on the conference contact your Roth representative or visit http://www.roth.com .

About Roth China Discovery Tour

The 3rd Annual China Discovery Tour will feature more than 70 companies in 7 cities throughout China, combining factory visits with management presentations in a mini conference format. This event is another chapter in Roth's growing commitment to China. Over the past two years Roth has taken investors on more than 60 company visits in mainland China and hosted close to 200 China company presentations at its conferences. For more information about this invite only event, please contact conference@roth.com.

About Tianyin Pharmaceuticals

Tianyin is a manufacturer and supplier of modernized Traditional Chinese Medicine ("TCM") in China. It was established in 1994 and acquired by the current management team in August 2003. It has a comprehensive product portfolio of 34 modernized TCMs in the market, 22 of which are listed in the highly selective National Medicine Catalog of the National Medical Insurance Program. Tianyin owns and operates two GMP manufacturing facilities and an R&D platform supported by leading Chinese academic institutions. The Company has a pipeline of 51 pharmaceutical products pending approval. Tianyin has an extensive nationwide distribution network throughout China with a sales force of 523 salespeople. Tianyin is headquartered in Chengdu, Sichuan Province with two manufacturing facilities and a total of 869 employees. Tianyin achieved revenue of $20.4 million and net income of $3.95 million in FY2007 ending June 30, 2007.

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please contact:

For the Company:

Allen Tang, Ph.D., MBA, Assistant to the CEO

Tel: +86-158-2122-5642 (China)

Email: Allen.y.tang@gmail.com

Investors:

HC International, Inc.

Alan Sheinwald

Tel: 1-914-669-0222 (US)

Email: Alan.Sheinwald@hcinternational.net


'/>"/>
SOURCE Tianyin Pharmaceutical, Co., Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Viscorp, Inc. Announces Name Change to Tianyin Pharmaceutical Co Inc. and Begins Trading Under the Ticker OTC BB: TYNP
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
7. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
11. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/15/2020)... ... February 14, 2020 , ... ... partnered with Baptist Easley Hospital , a member of Prisma Health, providing ... With PCPLUS, the world-class hospital was able to cut its monthly laundry management ...
(Date:2/15/2020)... ... ... It all started back in 2010, when Jennifer Martinez (Founder) was delighted that ... on to something special. The Heartsters have now become a circle of friends ... condition or illness, a disability or just having a bad day. , “It ...
(Date:2/14/2020)... ... February 14, 2020 , ... The Dr. Oz Show ... has segments on health, wellness and medical information. As an upcoming guest on the ... Linkov, will be sharing his in-depth medical knowledge. During the segment, Dr. Linkov, a ...
(Date:2/14/2020)... ... February 14, 2020 , ... “The American Society for ... texture and discoloration, and lines and wrinkles. And the treatments they are most ... great specials in February specifically to address the areas our patients are most ...
(Date:2/13/2020)... ... 2020 , ... Charles Seal-Villafranca, DHA(c), MSHA, CDP, ALFM-BC, the ... today his re-election as the President of the Arizona State Board of Examiners ... As President of the State Board, Villafranca acts as the chief judge to ...
Breaking Medicine News(10 mins):
(Date:2/10/2020)... ... February 10, 2020 , ... ... now offering EMSculpt treatments to patients. , EMSculpt is an FDA-approved treatment ... treat the abdomen, buttocks, thighs, calves, biceps, and triceps. The EMSculpt machine utilizes ...
(Date:2/10/2020)... OZARK, Mo. (PRWEB) , ... February 10, 2020 ... ... than 20 years of experience, most recently in home health and hospice, announced ... consultative-style revenue cycle management for home health and hospice agencies, regardless of EHR, ...
(Date:2/7/2020)... ... February 07, 2020 , ... MD&M, the ... Center. PI, a global leader in precision automation and piezo transducer technologies will ... selection of piezo transducers for medical applications. , Product Examples, A variety ...
Breaking Medicine Technology: